 |
Glycosmedia
publication |
| |
A number of companies have expressed an interest
in sponsoring Glycosmedia. If we can attract sufficient support
we will revert back to a weekly publication. If you are able support
us and would like further information then please contact Jim Young, Editor-in-chief |
| |
|
|
Depression
with a chronic physical health problem |
| |
The treatment and management of depression in
adults with chronic physical health problems (NICE, UK) |
| |
|
|
New
guidance on diabetes and depression |
| |
The National Institute for Health and Clinical
Excellence (NICE) has published guidance on the treatment and management
of depression in adults with chronic physical health problems,
including diabetes, heart disease and cancer (Diabetes UK) |
| |
|
|
Clinical
Knowledge Summaries - Management of Diabetes Type 2 |
| |
Clinical Knowledge Summaries (formerly PRODIGY)
are a reliable source of evidence-based information and practical
'know how' about the common conditions managed in primary care
(CKS, NHS) |
| |
|
|
Fear
of hypoglycaemia |
| |
Defining a minimum clinically important difference
in patients with type 2 diabetes (Health and Quality of Life Outcomes) |
| |
|
|
Mitochondrial
Function and Insulin Resistance in Overweight and Normal-Weight
Children |
| |
Reduced skeletal muscle mitochondrial oxidative
phosphorylation, assessed by PCr recovery, is associated with insulin
resistance and an altered metabolic phenotype in children (Journal
of Clinical Endocrinology & Metabolism) |
| |
|
|
Modern
insulins drive up Novo Nordisk earnings |
| |
Growth was driven by Novo's diabetes division,
where turnover climbed 12% to 9.27 billion kroner (PharmaTimes) |
| |
|
|
Sanofi-Aventis
and Wellstat Therapeutics Enter into an Exclusive Worldwide Licensing
Agreement for Novel Oral Agent to Treat Type II Diabetes |
| |
Under this agreement, sanofi-aventis will receive
an exclusive worldwide license to develop, manufacture and commercialize
PN2034 and related compounds (PharmaLive) |
| |
|
|
Exploring
the complex care of the diabetic foot ulcer |
| |
Diabetic foot ulcers are a complication affecting
approximately 15% of people with diabetes. Treating these ulcers
is costly, and the resulting disfigurement can be devastating (JAAPA) |
| |
|
|
Oxidative
Stress Markers Regulating the Healing of Foot Ulcers in Patients
With Type 2 Diabetes |
| |
A high level of lipid peroxidation accompanied
by insufficient antioxidant enzymes and decreased total antioxidant
status in plasma could contribute to the chronicity of an ulcer
and an extended inflammatory reaction. Thus, oxidative stress may
be regarded as an important factor for nonhealing diabetic foot
ulcers among patients with type 2 diabetes (Wounds) |
| |
|
|
Measuring
and estimating insulin resistance in clinical and research settings |
| |
This article covers several important issues
on the measurement of insulin secretion and resistance that had
not been well described in other review articles, and may be of
help for future clinical investigation (NMCD) |
| |
|
|
Decisions
About Intensity of Glycemic Control Should Depend on Age and
Functional Status |
| |
Decisions about intensive glycemic control in
older adults should consider life expectancy, which can be assessed
based on age and functional status. Older adults with limited life
expectancy are unlikely to benefit from intensive control compared
with moderate control (Clinical Diabetes) |
| |
|
|
Factors
Predictive of Use and of Benefit From Continuous Glucose Monitoring
in Type 1 Diabetes |
| |
Frequency of blood glucose meter monitoring
and initial CGM use may help predict the likelihood of long-term
CGM benefit in intensively treated patients with type 1 diabetes
of all ages (Diabetes Care) |
| |
|
|
Three-Year
Efficacy of Complex Insulin Regimens in Type 2 Diabetes |
| |
Patients who added a basal or prandial insulin-based
regimen to oral therapy had better glycated hemoglobin control
than patients who added a biphasic insulin-based regimen (NEJM) |
| |
|
|
Network
of vascular diseases, death and biochemical characteristics in
a set of 4,197 patients with type 1 diabetes |
| |
The complex pattern of links between diverse
characteristics and the lack of a single dominant factor suggests
a need for multifactorial and multidisciplinary paradigms for the
research, treatment and prevention of diabetic complications (Cardio
Vascular Diabetology) |
| |
|
|
Dieting
'keeps diabetes at bay' |
| |
A period of careful eating and regular exercise
can stave off diabetes for a decade, a study suggests (BBC, UK) |
| |
|
|
Diabetes
to hit one in seven |
| |
One in seven Australians is forecast to have
type 2 diabetes in 2050, at a cost of $14 billion in today's terms,
the National Centre for Social and Economic Modelling predicts
(The Age, Australia) |
| |
|
